Autopsy report · NCT04002310

A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“The trial was discontinued in the interests of patients considering benefit/risk balance.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 3 years before it stopped.
18 participants enrolled.
Results were posted on the registry 1 year 1 month after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Boehringer Ingelheim
Sponsor type: Industry
Conditions: Macular Degeneration
Interventions: BI 754132
Participants: 18
Sites: 13
Countries: United Kingdom, United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.